Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
High 6.66 at 2:00 pm ET, low 6.32 at 8:45 am ET.
Starling Oncology, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Nasdaq · Services-Offices & Clinics of Doctors of Medicine
120 managers report $233.3M of Starling Oncology, Inc. on form 13F for the quarter ended Jun 30 '26. 20 of them hold 80% of it; BlackRock, Inc. is largest at 11.05%.
95 more managers in the register
20 of 120 managers hold 80% of the $233.3M institutional base.
As filed for the quarter ended Jun 30, 79 days ago; this register does not move with the price above it.
TOI (Starling Oncology, Inc.) has 2 disclosed suppliers and 6 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for its filing sentence; select again to open the company. Nearer the centre, the more the filings disclose. Extended: satellites hang off single companies, not bundled sectors.
via Deerfield Management Co, Josh Arnold Investment Consultant, LLC, Wexford Capital LP +16 more · 7.82% of TOI, 7.82% of STLN
via Deerfield Management Co, Marshall Wace LLP · 7.82% of TOI, 36.86% of LRMR
via Wexford Capital LP, Marshall Wace LLP, Acadian Asset Management LLC +1 more · 3.98% of TOI, 9.98% of XGN
via Deerfield Management Co, Arrowstreet Capital, Limited Partnership · 7.82% of TOI, 8.04% of AHCO
via Deerfield Management Co, Marshall Wace LLP · 7.82% of TOI, 6.24% of SVRA
via Deerfield Management Co, Arrowstreet Capital, Limited Partnership, CenterBook Partners LP · 7.82% of TOI, 7.83% of LEGN
Managers with a meaningful stake in TOI, and their share of the other company’s institutional base; managers who hold nearly everything we cover are excluded. How the two are held, not evidence that one moves the other.